{"id":"https://openalex.org/W1996580151","doi":"https://doi.org/10.1158/1538-7445.am10-4033","title":"Abstract 4033: MiR-21 upregulation in breast cancer cells leads to PTEN loss and Herceptin resistance","display_name":"Abstract 4033: MiR-21 upregulation in breast cancer cells leads to PTEN loss and Herceptin resistance","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W1996580151","doi":"https://doi.org/10.1158/1538-7445.am10-4033","mag":"1996580151"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-4033","doi":"https://doi.org/10.1158/1538-7445.am10-4033","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-4033","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104109824","display_name":"Sumaiyah K. Rehman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sumaiyah K. Rehman","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062806463","display_name":"Wen\u2010Chien Huang","orcid":"https://orcid.org/0000-0002-9482-8188","observed_orcids":["https://orcid.org/0000-0002-9482-8188"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wen-Chien Huang","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040450464","display_name":"Dihua Yu","orcid":"https://orcid.org/0000-0001-6231-9381","observed_orcids":["https://orcid.org/0000-0001-6231-9381"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dihua Yu","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"4033","last_page":"4033"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.05640000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mir-21","display_name":"miR-21","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.6029999852180481},{"id":"https://openalex.org/keywords/trastuzumab-resistance","display_name":"trastuzumab resistance","score":0.9649999737739563},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9409999847412109},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.843999981880188},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.9459999799728394},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.7820000052452087},{"id":"https://openalex.org/keywords/microrna","display_name":"microRNA","score":0.6570000052452087},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7699999809265137},{"id":"https://openalex.org/keywords/3-utr-targeting","display_name":"3' UTR targeting","score":0.6959999799728394},{"id":"https://openalex.org/keywords/skbr-3-cells","display_name":"SK-BR-3 cells","score":0.984000027179718},{"id":"https://openalex.org/keywords/bt474-cells","display_name":"BT474 cells","score":0.9100000262260437},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.9344296455383301},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.7378936409950256},{"id":"https://openalex.org/C191560914","wikidata":"https://www.wikidata.org/wiki/Q7390592","display_name":"SKBR3","level":5,"score":0.7170753479003906},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.6953287720680237},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6871594786643982},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5200914144515991},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5049334168434143},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.5046716928482056},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4231281280517578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3944014012813568},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3909666836261749},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2798163890838623},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.23376166820526123},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2074587643146515},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.16106104850769043},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10941082239151001},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.08332952857017517},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-4033","doi":"https://doi.org/10.1158/1538-7445.am10-4033","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-4033","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2145848169","https://openalex.org/W2328071157","https://openalex.org/W2062074784","https://openalex.org/W2084400739","https://openalex.org/W2089149109","https://openalex.org/W1482814115","https://openalex.org/W2953546167","https://openalex.org/W3175017413","https://openalex.org/W2091054770","https://openalex.org/W1982475508"],"abstract_inverted_index":{"Abstract":[0],"MicroRNAs":[1],"(miRNA)":[2],"are":[3,226],"a":[4],"class":[5],"of":[6,16,27,70,76,88,100,187,231,238,261,266],"small":[7],"22-nucleotides":[8],"endogenous":[9],"non-coding":[10],"RNAs":[11,23],"which":[12,242],"serve":[13],"as":[14,37],"regulators":[15],"gene":[17],"expression":[18,26,138,169,200],"by":[19,40,98,125],"targeting":[20,42],"specific":[21],"messenger":[22],"(mRNA).":[24],"Aberrant":[25],"certain":[28],"microRNAs":[29],"can":[30],"lead":[31],"to":[32,74,144,174,219,233,249],"therapeutic":[33],"drug":[34],"resistance,":[35,241],"such":[36],"Cisplatin":[38],"resistance":[39,53,93],"miR-214":[41],"PTEN.":[43,101],"Our":[44],"lab":[45],"previously":[46],"found":[47,129,208],"that":[48,65,86,130,201,209],"PTEN":[49,71,77,137,168],"loss":[50],"confers":[51],"Herceptin":[52,92,126,145,175,205,220,251],"in":[54,60,94,115,158,194],"ErbB2-overexpressing":[55,116],"breast":[56,95,120,196],"cancers.":[57],"Other":[58],"studies":[59],"hepatocellular":[61],"carcinoma":[62],"have":[63],"shown":[64],"miR-21":[66,89,134,157,192,211,232,239],"targets":[67,230],"the":[68,164,184,236,262,267],"3\u2032UTR":[69],"mRNA":[72],"leading":[73],"downregulation":[75,99],"protein":[78],"levels.":[79],"Based":[80],"on":[81,247],"these":[82],"findings,":[83,189],"we":[84,154,190,207],"hypothesized":[85],"overexpression":[87],"may":[90,243],"confer":[91],"cancer":[96,121],"patients":[97],"To":[102,182],"test":[103],"this":[104],"hypothesis,":[105],"mir-21":[106],"and/or":[107],"control":[108,148,178],"miRNA":[109,149,179],"were":[110,140,202],"transiently":[111],"transfected":[112,150,180],"and":[113,118,139,170,206,222],"expressed":[114],"AU565":[117],"SKBr3":[119],"cell":[122],"lines,":[123],"followed":[124],"treatment.":[127],"We":[128,225],"cells":[131,165],"with":[132,198,204,215],"increased":[133,167],"had":[135],"reduced":[136],"significantly":[141,213],"more":[142,172],"resistant":[143],"treatment":[146,176,221],"versus":[147,177],"cells.":[151,181],"Conversely,":[152],"when":[153],"knocked":[155],"down":[156],"high":[159,210],"ErbB2":[160,199],"expressing":[161],"BT474":[162],"cells,":[163],"showed":[166],"became":[171],"sensitive":[173],"determine":[183],"clinical":[185],"relevance":[186],"our":[188],"detected":[191],"level":[193,212],"patients\u2019":[195,216],"cancers":[197],"treated":[203],"correlated":[214],"poor":[217],"response":[218],"disease":[223],"progression.":[224],"currently":[227],"identifying":[228],"other":[229],"better":[234],"understand":[235],"mechanisms":[237],"mediated-Herceptin":[240],"provide":[244],"new":[245],"insight":[246],"how":[248],"overcome":[250],"resistance.":[252],"Citation":[253],"Format:":[254],"{Authors}.":[255],"{Abstract":[256],"title}":[257],"[abstract].":[258],"In:":[259],"Proceedings":[260],"101st":[263],"Annual":[264],"Meeting":[265],"American":[268],"Association":[269],"for":[270],"Cancer":[271,281],"Research;":[272],"2010":[273],"Apr":[274],"17-21;":[275],"Washington,":[276],"DC.":[277],"Philadelphia":[278],"(PA):":[279],"AACR;":[280],"Res":[282],"2010;70(8":[283],"Suppl):Abstract":[284],"nr":[285],"4033.":[286]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}